The agency announced moves to cut regulatory obstacles for the makers of biosimilar drugs, which are akin to generics and may ...

Somehow, it’s becoming even harder to get a GLP-1.

Merck, which has claimed bragging rights as the maker of the world’s best-selling drug, Keytruda, since 2023, has officially ...

The Wegovy and Ozempic maker’s offer comes after Pfizer last month agreed to a lower deal to acquire the Nasdaq-listed ...

The U.S. Food and Drug Administration (FDA) has approved two new biosimilars as reference products for Prolia (denosumab) and ...

Merck and Eisai's experimental combination treatment for a type of kidney cancer met one of the main goals in a late-stage ...

Pharmacy benefit manager Prime Therapeutics is expanding its partnership with Sempre Health, a company that applies discounts at the pharmacy counter for people taking single-source drugs for chronic ...

The results could help expand use of Welireg, one of the medicines Merck is counting on to drive revenue growth when its ...

Gilead has chosen a partner for lenacapavir in the race to develop new low-frequency treatments for HIV. | Gilead has chosen ...

FDA Approves KYGEVVI® (doxecitine and doxribtimine), the First and Only Treatment for Adults and Children Living with Thymidine Kinase 2 deficiency (TK2d), a Rare and Devastating Mitochondrial Disease ...

Regular strength training and ensuring that you’re eating enough protein can help mitigate muscle loss, Dr. Ghosh says, but ...

A majority of PTSD sufferers—70 percent to almost 90 percent—develop sleep disturbances because they relive traumatic ...